Anika Therapeutics (ANIK) Current Leases (2019 - 2026)
Anika Therapeutics (ANIK) posted quarterly Current Leases of $1.9 million for Q2 2026, up 6.61% year-over-year from $1.8 million in Q2 2025, and little changed quarter-over-quarter from $1.9 million in Q1 2026.
Anika Therapeutics (ANIK) Current Leases (2019 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Current Leases for 8 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Leases rose 6.61% year-over-year to $1.9 million; the TTM figure through Jun 2026 stood at $1.9 million (up 6.61% YoY), while the FY2025 annual figure was $2.1 million, up 6.99% from the prior year.
- Current Leases steadied at $1.9 million in Q2 2026 per ANIK's latest filing, from $1.9 million in the prior quarter.
- Across five years, Current Leases topped out at $2.3 million in Q3 2024 and bottomed at $1.5 million in Q1 2022.
- Historically, Current Leases has averaged $2.0 million across 5 years, with a median of $1.9 million in 2026.
- Annual changes were most pronounced in 2022 — Current Leases soared 1184.03% — and 2025, when it fell 24.74%.
- Anika Therapeutics' Current Leases stood at $2.1 million in 2022, then decreased by 11.87% to $1.8 million in 2023, then gained by 4.98% to $1.9 million in 2024, then advanced by 6.99% to $2.1 million in 2025, then dropped by 5.7% to $1.9 million in 2026.
- Business Quant data shows ANIK's Current Leases at $1.9 million in Q2 2026, $1.9 million in Q1 2026, and $2.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | 2.05 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.87 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.13 Mn |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | 2.05 Mn |
| Jun 30, 2023 | 2.09 Mn |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | 2.07 Mn |
| Sep 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | 1.53 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Mar 31, 2021 | 119,000.00 |